Thyrocare Technologies
Thyrocare Technologies Share Price Chart
Thyrocare Technologies last traded at ₹514.65 (2026-10-13). Over the past month the stock moved -7.8%, three months the stock moved +2.5%, year the stock moved +28.0%. Its closing range over 52 weeks is ₹351.35 – ₹620.00, with the latest close 17.0% below the high.
Closing prices up to 2026-10-13.
About Thyrocare Technologies
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.
Business Segments 1) Diagnostic Testing Services (92% in FY25 vs 94% in FY22): [1] [2] The company is one of the leading Pan-India diagnostic chains, offering a range of tests focused on early disease detection and health management. It provides 929 tests and 288 profiles, including 43 wellness packages under the “Aarogyam” brand. It processes 3 Bn investigations annually and can process 10 Bn annually. [3] [4]
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Thyrocare Technologies reported sales of ₹240.00 crore (+24.4%) and net profit of ₹51.00 crore (+34.2%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 240.00 | 77.00 | 32.00 | 51.00 | 3.28 |
| Mar 2026 | 224.00 | 75.00 | 34.00 | 49.00 | 2.96 |
| Dec 2025 | 196.00 | 58.00 | 30.00 | 28.00 | 1.82 |
| Sep 2025 | 217.00 | 71.00 | 33.00 | 48.00 | 3.02 |
| Jun 2025 | 193.00 | 58.00 | 30.00 | 38.00 | 2.45 |
| Mar 2025 | 187.00 | 57.00 | 30.00 | 22.00 | 1.36 |
| Dec 2024 | 166.00 | 42.00 | 25.00 | 19.00 | 1.20 |
| Sep 2024 | 177.00 | 48.00 | 27.00 | 26.00 | 1.68 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +19.6% | +23.0% | +21.4% | +22.9% | +22.6% | +18.1% | +19.8% | +24.4% |
| Operating profit growth | +26.3% | +31.3% | +67.6% | +38.1% | +47.9% | +38.1% | +31.6% | +32.8% |
| Net profit growth | +30.0% | +26.7% | +29.4% | +58.3% | +84.6% | +47.4% | +122.7% | +34.2% |
| EPS growth | +31.3% | +23.7% | +21.4% | +61.2% | +79.8% | +51.7% | +117.6% | +33.9% |
| OPM % | 27.0% | 25.0% | 30.0% | 30.0% | 33.0% | 30.0% | 34.0% | 32.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Thyrocare Technologies reported sales of ₹829.00 crore (+20.7%) and net profit of ₹163.00 crore (+79.1%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 829.00 | 262.00 | 32.00 | 163.00 | 10.24 |
| Mar 2025 | 687.00 | 190.00 | 28.00 | 91.00 | 17.27 |
| Mar 2024 | 572.00 | 140.00 | 24.00 | 69.00 | 13.36 |
| Mar 2023 | 527.00 | 123.00 | 23.00 | 64.00 | 12.18 |
| Mar 2022 | 589.00 | 236.00 | 40.00 | 176.00 | 33.29 |
| Mar 2021 | 495.00 | 171.00 | 35.00 | 113.00 | 21.40 |
| Mar 2020 | 434.00 | 174.00 | 40.00 | 88.00 | 16.73 |
| Mar 2019 | 403.00 | 154.00 | 38.00 | 85.00 | 16.13 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +13.2% | +7.7% | +14.1% | +19.0% | -10.5% | +8.5% | +20.1% | +20.7% |
| Operating profit growth | +6.2% | +13.0% | -1.7% | +38.0% | -47.9% | +13.8% | +35.7% | +37.9% |
| Net profit growth | -8.6% | +3.5% | +28.4% | +55.8% | -63.6% | +7.8% | +31.9% | +79.1% |
| EPS growth | -7.1% | +3.7% | +27.9% | +55.6% | -63.4% | +9.7% | +29.3% | -40.7% |
| OPM % | 38.0% | 40.0% | 35.0% | 40.0% | 23.0% | 24.0% | 28.0% | 32.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Thyrocare Technologies.
Get Free AI Stock Analysis FREE →Latest News
-
Thyrocare Technologies Approves ₹141.40 Crore Nuclear Healthcare Sale; Shares Rise 3.09%
-
Thyrocare Technologies Approves ₹141.40 Crore Nuclear Healthcare Sale; Shares Rise 3.09%
-
Marry a working & frugal wife: Rs 5000-crore Thyrocare founder Velumani shares a must-do list for entrepreneurs who leave comfortable jobs to solve ‘world’s big problems’ - The Economic Times
-
API Holdings acquires 51% stake in Thyrocare via amalgamation scheme - scanx.trade
-
API Holdings acquires 51% stake in Thyrocare via amalgamation scheme - scanx.trade
-
API Holdings repays ₹1,050 crore, frees Thyrocare shares from pledge - BusinessLine
-
Pharmeasy parent clears Rs 1,050 crore debt, frees Thyrocare stake from pledge - The Economic Times
-
API Holdings repays ₹1,050 crore, frees Thyrocare shares from pledge - BusinessLine
-
Pharmeasy parent clears Rs 1,050 crore debt, frees Thyrocare stake from pledge - economictimes.indiatimes.com
-
Thyrocare Promoter Docon Offloads 9.9% Stake for Rs 986 Crore
Frequently Asked Questions
What is Thyrocare Technologies's current stock price?
Thyrocare Technologies shares were last quoted at ₹514.65 (+3.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Thyrocare Technologies?
Thyrocare Technologies has a price-to-earnings (P/E) ratio of 51.08 and a price-to-book (P/B) ratio of 14.17. The industry P/E is 102.59.
What is the 52-week high and low of Thyrocare Technologies?
The 52-week high of Thyrocare Technologies is ₹662.00 and the 52-week low is ₹342.55.
What is the market cap of Thyrocare Technologies?
The market capitalisation of Thyrocare Technologies is about ₹9,008.76 crore.
How did Thyrocare Technologies perform in its latest quarterly results?
In the latest quarter (Jun 2026), Thyrocare Technologies reported sales of ₹240.00 crore (+24.4%) and net profit of ₹51.00 crore (+34.2%), compared with the same quarter last year.
Is Thyrocare Technologies a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Thyrocare Technologies has a 3-year ROE of 20.00%, 3-year profit growth of 36.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Thyrocare Technologies?
Promoters hold about 60.92% of Thyrocare Technologies.
Which sector does Thyrocare Technologies belong to?
Thyrocare Technologies belongs to the Hospital & Healthcare Services sector.
Other Hospital & Healthcare Services stocks
- Apollo Hospitals Enterprises
- Max Healthcare Institute
- Manipal Health Enterprises
- Aster DM Quality Care
- Fortis Healthcare
- Global Health
- Narayana Hrudayalaya
- Krishna Institute of Medical Sciences
All Hospital & Healthcare Services stocks · Browse all stocks A–Z